Targeting the TGFβ signaling network in human neoplasia

被引:212
作者
Dumont, N
Arteaga, CL [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA
[3] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Comprehens Canc Ctr, Breast Canc Res Program, Nashville, TN 37232 USA
关键词
D O I
10.1016/S1535-6108(03)00135-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:531 / 536
页数:6
相关论文
共 50 条
[1]  
Ananth S, 1999, CANCER RES, V59, P2210
[2]  
ARTEAGA CL, 1993, CELL GROWTH DIFFER, V4, P193
[3]   ANTI-TRANSFORMING GROWTH-FACTOR (TGF)-BETA ANTIBODIES INHIBIT BREAST-CANCER CELL TUMORIGENICITY AND INCREASE MOUSE SPLEEN NATURAL-KILLER-CELL ACTIVITY - IMPLICATIONS FOR A POSSIBLE ROLE OF TUMOR-CELL HOST TGF-BETA INTERACTIONS IN HUMAN BREAST-CANCER PROGRESSION [J].
ARTEAGA, CL ;
HURD, SD ;
WINNIER, AR ;
JOHNSON, MD ;
FENDLY, BM ;
FORBES, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2569-2576
[4]   Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration [J].
Bakin, AV ;
Tomlinson, AK ;
Bhowmick, NA ;
Moses, HL ;
Arteaga, CL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :36803-36810
[5]  
Bandyopadhyay A, 1999, CANCER RES, V59, P5041
[6]  
Bandyopadhyay A, 2002, CANCER RES, V62, P4690
[7]  
Böttinger EP, 1997, CANCER RES, V57, P5564
[8]   TGF beta 1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice [J].
Cui, W ;
Fowlis, DJ ;
Bryson, S ;
Duffie, E ;
Ireland, H ;
Balmain, A ;
Akhurst, RJ .
CELL, 1996, 86 (04) :531-542
[9]   TGF-β signaling in tumor suppression and cancer progression [J].
Derynck, R ;
Akhurst, RJ ;
Balmain, A .
NATURE GENETICS, 2001, 29 (02) :117-129
[10]   Autocrine transforming growth factor-β signaling mediates smad-independent motility in human cancer cells [J].
Dumon, N ;
Bakin, AV ;
Arteaga, CL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :3275-3285